RNA-targeted therapeutics for lipid disorders.

08:00 EDT 17th September 2018 | BioPortfolio

Summary of "RNA-targeted therapeutics for lipid disorders."

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.


Journal Details

This article was published in the following journal.

Name: Current opinion in lipidology
ISSN: 1473-6535


DeepDyve research library

PubMed Articles [12894 Associated PubMed Articles listed on BioPortfolio]

Lipid disorders among Black Africans non-users of lipid-lowering medication.

Angola is a sub-Saharan African country where the population has scarce access to lipidlowering medication. We sought to determine the frequency of lipid disorders among Angolan nonusers of lipid-lowe...

Recent progress of drug nanoformulations targeting to brain.

Most of the potential therapeutic agents capable to modulate the pathophysiology or treat the neurological disorders and brain tumors are useless in the current modern and advanced era of neuroscience...

Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions.

Here, we review methods for enhancing the targeting efficiency and applications of LPHNPs. The novel formulations of LPHNPs have shown promising results for the targeted delivery of methotrexate to ad...

Add-on Therapy with Traditional Chinese Medicine: An Efficacious Approach for Lipid Metabolism Disorders.

Add-on therapy with traditional Chinese medicine (TCM) has been extensively researched in the intractable diseases, such as asthma, cancer, and Alzheimer's disease. As an entirely new concept, add-on ...

High-Throughput Measurement of Lipid Turnover Rates Using Partial Metabolic Heavy Water Labeling.

Novel analytical platforms for high-throughput determination of lipid turnover in vivo have been developed based on partial metabolic HO labeling. The performance on lipid kinetics measurement of our ...

Clinical Trials [5250 Associated Clinical Trials listed on BioPortfolio]

Genetic Origin of Lipid Disorders

Several lipid disorders are without known genetic origin. The scope of this project is to sequence genes superior involved in lipid and carbohydrate metabolism in patients with severe lipi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Digestion of Biopolymer Based Lipid Emulsions

In this randomized, double blind, unbalanced three way crossover trial, four lipid emulsions will be assessed on three study days. The lipid emulsions (LEs) have been engineered so that th...

Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism

Psoriasis and metabolic disorders are well-known mutual comorbidities. The investigators hypothesized metformin can ameliorate both psoriasis and metabolic disorders mainly via gut microbi...

Evaluation of Lipid Emulsion on GCX in Critically Ill Patients

Characterisation of the lipidome and parenteral nutrition modulate the endothelial glycocalyx. The aim of the study A is to detect any influence of the lipid emulsion on the endothelial ...

Medical and Biotech [MESH] Definitions

Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.

Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY).

Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES.

A family of vertebrate and insect lipid droplet associated proteins. They consist of a conserved N-terminal PAT domain (an alpha-helical region of about 110 amino acids), an 11-mer repeat region, and lipid-binding hydrophobic regions or 4-helix bundles near their C-termini. Perilipins transiently or constitutively localize to LIPID DROPLETS in ADIPOCYTES and FOAM CELLS, especially in regions adjacent to the PLASMA MEMBRANE and ENDOPLASMIC RECTICULUM. They are critical for lipid droplet synthesis and homeostasis as well as the regulation of lipid metabolism. Genetic variations in perilipins are associated with ATHEROSCLEROSIS; OBESITY; and DIABETES MELLITUS.

Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body.

Quick Search


DeepDyve research library

Searches Linking to this Article